Hi. I've read through some posts. I can't find anything on this.
But isn't this bad:
"ADVERSE REACTIONS
Clinical Trials Experience
[...]
Serious adverse reactions occurred in 35 patients (65%) including pyrexia (n=5;9%), respiratory failure (n=5;9%), pneumatosis intestinalis (n=4;7%) and staphylococcal bacteremia (n=2;<5%). Eight patients had discontinuation of RYONCIL treatment due to the following: acute infusion reactions (n=3), hypotension (n=1), gastroenteritis (n=1), and death (n=3)." -- ryoncil.com
Forgive me if I've got it completely wrong, or it's not related, or what have you.I'm more regular tech than biotech. But interested in this stock because of the approval and potential additional drugs they have.
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
0.010(0.44%) |
Mkt cap ! $2.963B | |||
| Open | High | Low | Value | Volume |
| $2.31 | $2.33 | $2.30 | $2.497M | 1.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 70 | 52952 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.31 | 125426 | 44 |
View Market Depth
| Last trade - 12.41pm 13/08/2025 (20 minute delay) ? |
| MSB (ASX) Chart |